SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Total Assets | ₹405 Cr | ₹378 Cr | ₹308 Cr | ₹184 Cr | ₹181 Cr |
What is the latest Total Assets ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Total Assets |
---|---|
Mar2024 | ₹405 Cr |
Mar2023 | ₹378 Cr |
Mar2022 | ₹308 Cr |
Mar2017 | ₹184 Cr |
Mar2016 | ₹181 Cr |
How is Total Assets of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Total Assets | % Change | |
---|---|---|---|
Mar2024 | ₹405 Cr | 7.10 | |
Mar2023 | ₹378 Cr | 22.58 | |
Mar2022 | ₹308 Cr | 67.59 | |
Mar2017 | ₹184 Cr | 1.81 | |
Mar2016 | ₹181 Cr | - |
Compare Total Assets of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,003.1 Cr | 0.3% | 26.8% | 81% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 0.3% |
26.8% |
81% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses